• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Up 0.19%

    Neurocrine Biosciences, Inc. (NBIX)

    -NasdaqGS
    41.98 Up 0.48(1.16%) Mar 24, 4:00PM EDT
    Prev Close:41.50
    Open:41.65
    Bid:33.00 x 100
    Ask:N/A
    1y Target Est:67.33
    Beta:1.74807
    Earnings Date:May 3 - May 8 (Est.)
    Day's Range:41.38 - 42.26
    52wk Range:33.56 - 55.15
    Volume:462,606
    Avg Vol (3m):1,048,530
    Market Cap:3.66B
    P/E (ttm):N/A
    EPS (ttm):-1.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXUp 1.16%3.66B
    LLYDown 0.28%88.61B
    PFEDown 0.85%202.47B
    ABTDown 0.09%77.29B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):241.02
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-17) :-2.28
    Quarterly EPS Est (Mar-17) :-0.74
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback